Remove 2018 Remove Chronic Pain Remove Clinical Trials Remove Epilepsy
article thumbnail

Cannabis laws in Jordan

The Cannigma

However, in 2019, the Jordanian government announced its plans to conduct clinical trials on the use of cannabis for medical purposes. 1 Hemp in Jordan In 2018, the Jordanian government legalized the cultivation of industrial hemp for certain purposes, such as the production of textiles and building materials.

Law 52
article thumbnail

The Science Behind Medical Marijuana: Exploring Cannabinoids and Their Therapeutic Effects

MMJ Recs

Both THC and CBD have demonstrated analgesic properties, making them valuable for managing chronic pain conditions such as arthritis, fibromyalgia, and cancer-related pain. This breakthrough has provided new hope to patients with severe forms of epilepsy who had previously found little relief from conventional treatments.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Cannabis: Good or Bad for Human Health  

Cannabis Law Report

Chronic pain. One area that reports looked closely was, use of medical marijuana to treat chronic pain. Chronic pain is a foremost cause of disability that affects more than 25 million adults in the U.S. Chronic pain is a foremost cause of disability that affects more than 25 million adults in the U.S.

article thumbnail

The Top Medical Cannabis Research of 2017

MGC Pharma

The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.

article thumbnail

‘Too costly, not enough evidence it works’, says UK in blow to cannabis campaigners

Cannabis Law Report

The watchdog refused to allow its national health service to prescribe medical cannabis for children with severe epilepsy because there is “not enough evidence it works”, a decision which angered campaigners and parents who said their children will suffer as a result. The final guideline is expected to be published in November 2019.

article thumbnail

Use of Cannabis-based medicinal products: NICE guidelines

Cannabis Law Report

Chronic pain. Severe treatment-resistant epilepsy. Chronic pain. Do not offer the following to manage chronic pain in adults: nabilone. Do not offer CBD to manage chronic pain in adults unless as part of a clinical trial. 1.4 Severe treatment-resistant epilepsy.

article thumbnail

MyMD Pharmaceuticals President Chris Chapman, M.D. Named Medical Honoree of the Year by the Arthritis Foundation

Cannabis Law Report

MyMD plans to advance MYMD-1 in the clinic with two simultaneous Phase 2 trials beginning in the current quarter, one for delaying aging and prolonging healthy lifespan, and the second for COVID-19-associated depression and cytokine elevation. 1 Data published by Research and Markets, March 2018. Dr. Chapman Bio. 646) 421-9523.